What do you see as the biggest obstacle to the pharmaceutical industry in drug discovery and effectively treating more diseases? Prakash: AI needs a lot of data for training, and then when you ask for something similar, it knows what to predict. Have other companies tried using physics modelling for drug discovery? Organisations like Schrӧdinger and CCDC have been selling physics-based modelling tools for almost three decades. What recent advances in molecular physics modelling are making drug discovery more feasible?